Pharmacological actions and therapeutic uses of cannabis and cannabinoids

Anaesthesia

Volumn 56, Issue 11, 2001, Pages 1059-1068

  Kumar, R N ^a   Chambers, W A ^a   Pertwee, R G ^b  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Ataractics: marijuana; Pharmacology

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID DERIVATIVE; CANNABIS DERIVATIVE; CODEINE; DRONABINOL; LEVONANTRADOL; LIGAND; NABILONE; OPIATE AGONIST; TETRAHYDROCANNABINOL DERIVATIVE;

ANALGESIC ACTIVITY; ANESTHESIA MECHANISM; ANTIEMETIC ACTIVITY; APPETITE DISORDER; CANNABIS ADDICTION; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENTIATION; DRUG RESEARCH; EPILEPSY; EUPHORIA; EXPERIMENTAL MODEL; GLAUCOMA; HUMAN; NONHUMAN; PAIN; REVIEW; SENSORY DYSFUNCTION; SPASTICITY; TACHYCARDIA;

ANESTHESIA; CANNABINOIDS; CANNABIS; DRUG INTERACTIONS; HUMANS; MUSCLE SPASTICITY; PAIN; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0034766553     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2001.02269.x     Document Type: Review

References (79)

1. Adverse effects of cannabis
2. Cannabis
3. Pharmacology and potential therapeutic uses of cannabis
4. Cannabis: Pharmacology and toxicology in animals and humans
5. The health and psychological consequences of cannabis use
6. 2 receptors
7. Cannabis and cannabinoids: Pharmacology and rationale for clinical use
8. Advances in cannabinoid receptor pharmacology
9. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
10. 1 receptors in the rat central nervous system
11. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
12. Pharmacology of cannabinoid receptor ligands
13. Endocannabinoids
14. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
15. Anandamide transport inhibition by the vanilloid agonist olvanil
16. 2 cannabinoid receptors of L759633, L759656 and AM630
17. Cannabinoid receptors and pain
18. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
19. Cannabinoid-induced nociception is mediated by a spinal alpha-2 noradrenergic mechanism
20. Spinal and supraspinal components of cannabinoid-induced nociception
21. Spinal cannabinoids are antiallodynic in rats with persistent inflammation
22. Two distinctive antinoceptive systems in rats with pathological pain
23. Investigation of brain sites mediating cannabinoid induced antinociception in rats: Evidence supporting peri-aqueductal grey involvement
24. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects
25. Antinociceptive activity in intrathecally administered cannabinoids alone, and in combination with morphine, in mice
26. Dimethylheptyl-THC-11oic acid. A nonpyschoactive antiinflamatory agent with a cannabinoid template structure
27. The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
28. Marijuana carry over effects on aircraft pilot performance
29. Health consequences of acute and chronic marihuana use
30. Health aspects of cannabis
31. Cannabinoid induces hypotension and bradycardia in rats is mediated by CB-1 like cannabinoid receptors
32. Effect of smoked marijuana on human performance: A critical review
33. Marijuana and immunity
34. Respiratory effects of non-tobacco cigarettes
35. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana and/or tobacco
36. Marijuana smoking and carcinoma of the tongue. Is there an association?
37. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at an early age
38. Effects of marijuana and cannabinoids on reproduction, endocrine function, development and chromosomes
39. Perinatal exposure to tobacco and marijuana; Effects during pregnancy, infancy and early childhood
40. Early onset cannabis use and psychosocial adjustment in young adults
41. Marijuana; Harder than thought?
42. An evaluation of the history of marijuana withdrawal syndrome in a large population
43. Psychotic reactions following cannabis use in East Indians
44. Marihuana as a therapeutic agent for muscle spasm or spasticity
45. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis
46. Tetrahyrocannabinol for tremor in multiple sclerosis
47. Nabilone in the treatment of multiple sclerosis
48. The perceived effects of cannabis smoking in patients with multiple sclerosis
49. The perceived effects of marijuana on spinal cord injured males
50. Cannabis effect on spasticity in spinal cord injury
51. Delta-9-THC shows antispastic and analgesic effects in a single case double blind trial
52. Marijuana for Parkinsonian tremor
53. Results of a standardized survey on the medical use of cannabis products in the German speaking area
54. Clinical experience of the synthetic cannabinoid nabilone for chronic pain
55. Short term effect of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers
56. The analgesic properties of delta-9-tetrahyrocannabinol
57. The analgesic properties of delta-9-THC and codeine
58. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain
59. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response
60. Lack of effect of cannabidiol in sustained neuropathia
61. Pain relief with oral cannabinoids in familial Mediterranean fever
62. Anti-emetic efficacy and toxicity of Nabilone, a synthetic cannabinoid, in lung cancer chemotherapy
63. A double blind controlled trial of Nabilone vs prochlorperazine for refractory emesis induced by cancer chemotherapy
64. Dronabinol as treatment for anorexia associated with weight loss in patients with AIDS
65. Chronic administration of cannabidiol to healthy volunteers and epileptic patients
66. Effect of marihuana on intraocular and blood pressure in glaucoma
67. Acute effects of marihuana on airway dynamics in spontaneously and experimentally produced bronchial asthma
68. The quasi morphine withdrawal syndrome: Effect of cannabinol, cannabidiol and terahydrocannabinol
69. 1) receptors by SR 141716 selectively antagonizes drug induced reinstatement of exploratory behaviour in gerbils
70. 1 cannabinoid receptor antagonist, SR 141716
71. The medical use of cannabis
72. Tolerance to and dependence on psychotropic cannabinoids
73. Clinical studies of cannabis tolerance and dependence
74. Preoperative marijuana inhalation and airway concern
75. Neuropharmacology and therapeutic potential of cannabinoids
76. Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol